search
Back to results

Comparing Urinary Tract Infections in Children With Spina Bifida Using Two Types of Catheters for Catheterization

Primary Purpose

Neurogenic Bladder, Spina Bifida

Status
Completed
Phase
Not Applicable
Locations
Canada
Study Type
Interventional
Intervention
Intermittent catheterization
Sponsored by
University of Alberta
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Neurogenic Bladder focused on measuring Neurogenic bladder, Spina bifida, Intermittent catheterization, Urinary tract infections

Eligibility Criteria

3 Months - 18 Years (Child, Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Healthy Child with spina bifida who requires clean intermittent catheterization (CIC) for ongoing bladder management.
  • Child either self catheterizes or receives catheterization by a consistent person.
  • Child/parent/caregiver able to read and understand English in order to consent to participation in the study and to respond to verbal questions about the experience and satisfaction with the catheter.

Exclusion Criteria:

  • Urethral deformities (i.e. stricture, false passage)
  • Antibiotic prophylaxis
  • Allergy to PVC product
  • Diabetes Mellitus
  • Unwilling to reuse catheters
  • History of bladder pathology (ie. tumours, calculus)
  • Surgical history of augmentation (cystoplasty, continent diversion)

Sites / Locations

  • Alberta Children's Hospital
  • University of Alberta
  • BC Children's Hospital
  • Winnipeg Children's Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

Polyvinyl Chloride Catheter

Hydrophilic catheter

Arm Description

Re-use clean polyvinyl chloride catheters for intermittent catheterization of children with spina bifida.

Use hydrophilic catheters (Speedicath) for intermittent catheterization of children with spina bifida.

Outcomes

Primary Outcome Measures

Symptomatic urinary tract infection (UTI)
Symptomatic urinary tract infection (UTI) as per CDC definitions

Secondary Outcome Measures

Subject satisfaction
Comparative data between polyvinyl chloride (PVC) and hydrophilic catheter on convenience, comfort, ease of handling, continuing to use, and overall satisfaction recorded on validated Satisfaction Questionnaire by subject

Full Information

First Posted
December 16, 2010
Last Updated
June 19, 2013
Sponsor
University of Alberta
search

1. Study Identification

Unique Protocol Identification Number
NCT01263392
Brief Title
Comparing Urinary Tract Infections in Children With Spina Bifida Using Two Types of Catheters for Catheterization
Official Title
A Comparison of the Incidence of Symptomatic Urinary Tract Infections in Children With Spina Bifida Using Hydrophilic or Non-hydrophilic Polyvinyl Chloride Catheters for Clean Intermittent Catheterization: a Randomized Cross Over Trial
Study Type
Interventional

2. Study Status

Record Verification Date
March 2013
Overall Recruitment Status
Completed
Study Start Date
April 2007 (undefined)
Primary Completion Date
January 2013 (Actual)
Study Completion Date
January 2013 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of Alberta

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The primary aim of this study was to determine if using the SpeediCath hydrophilic catheter would reduce the incidence of symptomatic urinary tract infections (UTI)in children with spina bifida who perform clean intermittent catheterization for bladder management. The hypothesis was that the incidence of symptomatic urinary tract infections would be significantly reduced (by 25%) in users of the SpeediCath hydrophilic catheter when compared to users of a reused polyvinyl chloride (PVC) catheter. Subjects were randomly assigned to either starting the study with PVC catheter for 6 months followed by the hydrophilic catheter for 6 months or visa versa. Each subject kept a weekly diary recording urinary tract infections symptoms, hematuria determined by urine dipstick, physician visits, days of missed school and other activities. At the end of each 6 months subjects completed a questionnaire recording their comfort and satisfaction in using the PVC or hydrophilic coated catheter. 70 subjects were randomized and 46 had complete data. There were no differences in febrile UTI, antibiotic use, healthcare visits or school days missed. The incidence of self reported UTI was lower in the PVC group than the hydrophilic group. 40% of subjects indicated that the hydrophilic coated catheter was slippery and difficult to handle compared to 10% for the PVC catheter. However overall satisfaction was no different between products. The study results are consistent with the current Cochrane Review that there is a lack of evidence to state that the incidence of UTI is affected by multiuse or hydrophilic catheter use.
Detailed Description
Intermittent catheterisation (IC) is accepted management for maintaining bladder and renal health in individuals with incomplete bladder emptying. Two common products are available for IC: polyvinyl chloride (PVC) and single use hydrophilic coated PVC. In 2004 the UK spent around £33 million on hydrophilic catheters compared to £3 million for PVC catheters. Proposed advantages of the lubricated hydrophilic catheter over PVC catheters are: lower incidence of symptomatic urinary tract infections (UTI) and lower incidence of urethral irritation, trauma and urethral strictures from repeated IC. Complications and UTIs are costly to the individual and the system but despite over 25 RCTs on the topic, there remains a lack of evidence indicating superiority of one product over another in community dwelling IC users. Purpose: To compare the incidence of symptomatic UTI in children with spina bifida using single use hydrophilic (SpeediCath™) or PVC catheters for IC. Secondary aims: compare differences in weekly urinalysis for blood and leukocytes; physician visits, antibiotic use, days missed of school or activities; subject and care provider satisfaction with study catheter products. Study Design, materials and methods: Randomised crossover two arm trial at four Western Canada paediatric sites: each arm was 24 weeks of single use hydrophilic or PVC catheters cleaned with soap and water (standard of care). Symptomatic UTI defined as positive leukocytes plus > 1 fever, flank pain, increased incontinence, malaise, cloudy or odorous urine requiring antibiotic treatment. Randomisation was determined at the study centre using a computer generated list into random block sizes of 8. Subject assignments were placed in opaque envelopes and sealed. After consent was obtained the local research assistant contacted the site technician who opened the envelope and gave the assignment. Sample size: With power of 80%, an expected difference of 25% between treatment and control and α 0.05, the total sample size needed was 97 subjects, using methods for correlated binary data and repeated measures. All data was entered by an impartial technician. It was not possible to blind subjects to product. Data were analyzed using a Mixed Within-Subjects Between-Subjects Analysis of Variance where the group was defined by the catheter type on which the trial began. SPSS version 20 was used for all analyses. Inclusion Criteria: Child with spina bifida living in the community who either self IC or received IC by a consistent person; child/parent/caregiver able to read and understand English. Exclusion criteria: Urethral deformities (i.e. stricture, false passage); antibiotic prophylaxis; allergy to PVC product; diabetes mellitus; history of bladder pathology (i.e. tumours, calculus); surgical history of augmentation (cystoplasty, continent diversion). Results: 70 subjects were randomized; 46 had complete data over 48 weeks; 24 dropouts: hydrophilic catheter too slippery (15%); refused PVC arm because they preferred hydrophilic catheter (5%); booked for continent diversion (4%), other (8%). Mean age 10.6 (SD 6.2), 21 males and 25 females. All performed IC > 3/day: 52% self and 48% parents/ caregivers; PVC catheters were used at least 5 times. Mean total weeks of self-reported UTI was 3.6 (SD 4.7) in the hydrophilic group vs. 2.3 (SD 3.3) in the PVC group (p= <.001) but no statistical differences in weeks of febrile UTI, antibiotic use, visits to physicians, days missed from school, or microscopic haematuria (urine dip). There was a trend to fewer weeks of positive leukocytes in the hydrophilic group (Table 1). There were no statistically significant differences in Convenience or Comfort. Ease of Handling was significantly different with 40% disliking the hydrophilic product compared to 10% for the PVC product. Fewer participants answered "yes" to "would you continue using the product" (hydrophilic vs. the PVC 65% vs. 90% respectively). However, overall satisfaction was no different between products (Table 2). Interpretation of Results: The study was underpowered despite major attempts at recruitment. However the findings are clinically relevant. The hydrophilic catheter was more difficult to handle and therefore less likely to be continued than the PVC multiuse product. Participants who overcame the handling issues found the product excellent. Incidence febrile UTI or of antibiotic treated UTI did not appear to be affected by single use vs. multiuse products. Conclusions: A hydrophilic catheter does not appear to reduce febrile UTI or antibiotic use in community dwelling children using CIC. Attrition was high based on participants' lack of adjustment to the hydrophilic product and to study fatigue. The study results are consistent with the existing Cochrane Review: there is a lack of evidence to state the incidence of UTI is affected by multiuse or hydrophilic catheter use. Large multicentre trials are strongly recommended. Table 1: Mean number of weeks (of 24) with Symptoms Hydrophilic Single Use PVC multiuse N Mean N Mean Leucocytes 50 8.46 52 10.10 Fever 50 .04 49 .06 Other Symptoms ( w no Fever) 50 3.50 49 2.22 Hematuria 50 2.64 52 3.15 Antibiotics 50 .80 49 .55 Days Missed Activities 50 .40 52 .13 Note: all comparisons p>0.05 Table 2: Overall satisfaction with catheter products Hydrophilic Single Use PVC multiuse N % Acceptable N % Acceptable Convenience 49 81.6 48 81.3 p>0.05 Comfort 48 87.5 47 95.7 p>0.05 Ease of handling 49 59.2 48 95.8 p<0.05 Would you continue to use? 49 57.1 48 91.7 p<0.05 Overall satisfaction 48 72.9 48 87.5 p>0.05

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Neurogenic Bladder, Spina Bifida
Keywords
Neurogenic bladder, Spina bifida, Intermittent catheterization, Urinary tract infections

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
46 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Polyvinyl Chloride Catheter
Arm Type
Active Comparator
Arm Description
Re-use clean polyvinyl chloride catheters for intermittent catheterization of children with spina bifida.
Arm Title
Hydrophilic catheter
Arm Type
Active Comparator
Arm Description
Use hydrophilic catheters (Speedicath) for intermittent catheterization of children with spina bifida.
Intervention Type
Device
Intervention Name(s)
Intermittent catheterization
Other Intervention Name(s)
Polyvinyl Chloride, Hydrophillic - Coloplast Speedicath catheter
Intervention Description
Subjects will use each type of catheter for 6 months and will report weekly in a diary on urinary tract infections (UTIs), urine dip for haematuria & leukocytes, antibiotic use, and days missed school; and will answer a Satisfaction questionnaire at the end of each 6 month arm.
Primary Outcome Measure Information:
Title
Symptomatic urinary tract infection (UTI)
Description
Symptomatic urinary tract infection (UTI) as per CDC definitions
Time Frame
6 months and 6 months at crossover
Secondary Outcome Measure Information:
Title
Subject satisfaction
Description
Comparative data between polyvinyl chloride (PVC) and hydrophilic catheter on convenience, comfort, ease of handling, continuing to use, and overall satisfaction recorded on validated Satisfaction Questionnaire by subject
Time Frame
6 months and 6 months at cross over
Other Pre-specified Outcome Measures:
Title
urinalysis (urine dipstick)
Description
urinalysis --- presence of leukocytes, haematuria as measured by subject and recorded in weekly diary
Time Frame
6 months and 6 months at crossover points
Title
Antibiotic use for any reason
Description
Antibiotic use recorded by subject
Time Frame
6 months and 6 months at cross over points
Title
Physician or healthcare provider visits
Description
physician visits for any reason
Time Frame
6 months and 6 months at crossover points
Title
Effect on daily activities
Description
days missed of school or activities as recorded by subject in weekly diary
Time Frame
6 months and 6 months at crossover

10. Eligibility

Sex
All
Minimum Age & Unit of Time
3 Months
Maximum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Healthy Child with spina bifida who requires clean intermittent catheterization (CIC) for ongoing bladder management. Child either self catheterizes or receives catheterization by a consistent person. Child/parent/caregiver able to read and understand English in order to consent to participation in the study and to respond to verbal questions about the experience and satisfaction with the catheter. Exclusion Criteria: Urethral deformities (i.e. stricture, false passage) Antibiotic prophylaxis Allergy to PVC product Diabetes Mellitus Unwilling to reuse catheters History of bladder pathology (ie. tumours, calculus) Surgical history of augmentation (cystoplasty, continent diversion)
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Katherine N Moore, PhD
Organizational Affiliation
University of Alberta
Official's Role
Principal Investigator
Facility Information:
Facility Name
Alberta Children's Hospital
City
Calgary
State/Province
Alberta
Country
Canada
Facility Name
University of Alberta
City
Edmonton
State/Province
Alberta
ZIP/Postal Code
T6G 2G3
Country
Canada
Facility Name
BC Children's Hospital
City
Vancouver
State/Province
British Columbia
Country
Canada
Facility Name
Winnipeg Children's Hospital
City
Winnipeg
State/Province
Manitoba
Country
Canada

12. IPD Sharing Statement

Learn more about this trial

Comparing Urinary Tract Infections in Children With Spina Bifida Using Two Types of Catheters for Catheterization

We'll reach out to this number within 24 hrs